John Sellers

Cooley advised Archon Biosciences, a biotechnology company pioneering computationally designed antibody cages (AbCs) to unlock powerful therapeutic targets beyond the reach of existing modalities, on its $20 million seed financing led by Madrona Ventures.

Cooley advised Decagon, an innovator in artificial intelligence (AI) customer support agents, on its $65 million Series B financing round, bringing its total amount raised to $100 million.

Cooley advised Socket, a cybersecurity platform that protects companies from software supply chain attacks, on its $40 million Series B financing, bringing its total funding to $65 million.

Cooley advised Logik.io, the company that reimagines configure, price and quote (CPQ) and consumerizes enterprise selling experiences, on its $25 million Series B funding to accelerate CPQ innovation and further expand company growth.

Cooley advised Candid Therapeutics, a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, on its $370 million debut capital raise and three-way merger with Vignette Bio and TRC 2004.